Cite
Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.
MLA
Palasiewicz, Karol, et al. “Tofacitinib Therapy Intercepts Macrophage Metabolic Reprogramming Instigated by SARS-CoV-2 Spike Protein.” European Journal of Immunology, vol. 51, no. 9, Sept. 2021, pp. 2330–40. EBSCOhost, https://doi.org/10.1002/eji.202049159.
APA
Palasiewicz, K., Umar, S., Romay, B., Zomorrodi, R. K., & Shahrara, S. (2021). Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein. European Journal of Immunology, 51(9), 2330–2340. https://doi.org/10.1002/eji.202049159
Chicago
Palasiewicz, Karol, Sadiq Umar, Bianca Romay, Ryan K Zomorrodi, and Shiva Shahrara. 2021. “Tofacitinib Therapy Intercepts Macrophage Metabolic Reprogramming Instigated by SARS-CoV-2 Spike Protein.” European Journal of Immunology 51 (9): 2330–40. doi:10.1002/eji.202049159.